Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Continuous Flow Chemistry. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111072515B reveals a green continuous flow method for cephalosporin intermediates, offering significant cost reduction and supply chain stability for global pharma manufacturers.
Patent CN117886701A reveals a safer continuous flow method for 4-nitrophenylethylamine. Achieve high purity and supply chain reliability with scalable manufacturing.
Patent CN115611769A reveals a continuous flow method for sartanbiphenyl. Enhance safety and yield in API intermediate manufacturing with this novel Kumada coupling approach.
Patent CN111886235A reveals a continuous flow method for Trazodone. Achieve high purity, reduced toxicity, and scalable API intermediate manufacturing.
Patent CN111704555A reveals a safer continuous flow method for 4-methoxy-2-nitroaniline. Achieve >99% purity and reduced costs in omeprazole intermediate manufacturing.
Patent CN113200860B reveals high-purity SGLT2 inhibitor intermediate via flow chemistry. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Patent CN114014768A details a barium-free continuous flow synthesis for high-purity tranexamic acid, offering significant cost reduction in API manufacturing and enhanced supply chain safety.
Discover a cost-effective, high-yield synthesis method for trifluoromethyl-substituted benzo[1,8]naphthyridine with >85% yield. Ideal for OLED materials development. Scale to 100 MT/yr with NINGBO INNO PHARMCHEM.
Solve supply chain risks with rhodium-catalyzed C-H activation for trifluoromethyl benzo[1,8]naphthyridine. 85%+ yields, cheap raw materials, and scalable production for organic luminescent materials.
Solve high-cost Boc protection in Taladegib synthesis. Our CDMO expertise delivers 92% yield with 5-step route, ensuring GMP compliance and supply chain stability.
Discover how metal-free carbonyl-bridged biheterocyclic synthesis eliminates CO gas hazards, reduces costs, and enables scalable production for pharmaceutical intermediates.
Solve high-cost catalysts & harsh conditions in benzothiazole synthesis. New CO2-based method achieves 85.9% yield at 80°C. Contact for CDMO solutions.
Eliminate metal catalysts and inert gas requirements in quinoline synthesis. Our CDMO expertise ensures scalable, green production for antimalarial drugs and PDE4 inhibitors.
Avoid heavy metal catalysts and anhydrous conditions in pyrido[1,2-a][1,3,5]-triazin-4-one synthesis. Reduce production costs and supply chain risks with this scalable, high-yield method.
Solve high-cost, low-yield issues in tegrazan intermediate production. New route achieves ≥99% purity with simplified steps and 100kgs+ scale capability.
Discover how metal-free, photo-catalyzed synthesis of perfluoroalkyl benzimidazoloisoquinolinones reduces costs and supply chain risks for pharmaceutical intermediates. Contact us for custom synthesis.
Solve chiral ligand supply chain risks with this metal-free synthesis. 86% yield, no resolution needed. Contact for custom production.
Discover how electrochemical catalysis eliminates metal catalysts and harsh conditions in benzyl alcohol production, reducing costs and supply chain risks for pharmaceutical intermediates. Contact us for scalable solutions.
Solve supply chain risks with metal-free, high-yield synthesis of trifluoromethyl selenium azaspiro[4,5]-tetraenone. Reduce costs and ensure 99% purity for pharma R&D and production.
Overcome chiral resolution challenges in Niraparib manufacturing. New metal-free synthesis achieves 97.51% purity with 26.75% overall yield. Reduce equipment costs and supply chain risks.